Disease/Infection News

RSS

Seropositive partners increase risk of COVID-19 but not obstetric complications in pregnant women

While earlier studies have shown the significance of serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant women, their partners have largely been excluded. Now, a new Danish study published on the preprint server medRxiv in September 2020 reports the impact of serologic testing in both pregnant women and their partners, as well as their newborns.

17 Sep 2020

Study shows why bacterial cells behave differently on different types of surfaces

These results from studies in both experimental and theoretical physics may help to improve antibacterial surfaces. The research work was recently published in the journal 'Nanoscale'.

17 Sep 2020

Higher viral loads can increase mortality rate in patients hospitalized with COVID-19 and cancer

Higher viral loads are associated with a greater risk of death among cancer and non-cancer patients hospitalized with coronavirus disease 2019 (COVID-19), researchers report September 15 in the journal Cancer Cell.

17 Sep 2020

Blood viscometers could help guide the treatment of Covid-19 patients

One of the biggest challenges facing medical teams treating Covid-19 patients is identifying which ones are likely to suffer the most extreme responses to the virus.

17 Sep 2020

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Sep 2020

Data scientists use Zhores supercomputer to identify the severity of COVID-19

As part of the anti-COVID-19 program of the Skoltech Center for Computational and Data-Intensive Science and Engineering (CDISE), Care Mentor AI data scientists used Skoltech's Zhores supercomputer to enhance pathology detection accuracy.

17 Sep 2020

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

In a study published on the bioRxiv preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of the antihistamine azelastine to inhibit SARS-CoV-2 infection in human nasal tissue in vitro.

16 Sep 2020

Changes in risk perception and protective behavior during coronavirus pandemic

In the first week of the coronavirus pandemic, people living in the United States underestimated their chances of catching the virus, or of getting seriously ill from the virus, according to a recently published Caltech-led study.

16 Sep 2020

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug's reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.

16 Sep 2020

Pandemic spread could make more people susceptible to xenophobia, racism

When viruses, parasites and other pathogens spread, humans and other animals tend to hunker down with immediate family and peer groups to avoid outsiders as much as possible.

16 Sep 2020

Conditions linked to obesity leave the lungs of obese patients more susceptible to COVID-19

Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife.

16 Sep 2020

New York City’s initial lockdown reduced coronavirus spread by 70 percent, study says

A team of researchers at Columbia University and the New York City Department of Health and Mental Hygiene have shown that this move by the government was effective in reducing the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19).

16 Sep 2020

CDC reports low mortality among children from COVID-19, but minorities are at risk

In the United States, the U.S. Centers for Disease Control and Prevention (CDC) reports 121 deaths among young people under the age of 21. Children from ethnic and racial minorities, those with underlying medical conditions, and in this age group, those between the ages of 18 and 20 are more likely to die from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

16 Sep 2020

SARS-CoV-2 with D614G mutation is prevalent in central India

A team of scientists at the Defence Research and Development Establishment, India, reveals that there are multiple viral introduction events in central India, and SARS-CoV-2 with D614G mutation is the prevalently circulating strain.

16 Sep 2020

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

In a promising study by US researchers, the receptor-binding domain (RBD) and stabilized spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were displayed on nanoparticles as vaccine antigens and elicited potent immune responses.

16 Sep 2020

Low birth weight appears to increase risk of severe COVID-19 in adults

Researchers in Barcelona, Spain have conducted a study showing that low birth weight seems to be an independent risk factor for severe illness among non-elderly adults with coronavirus disease 2019 (COVID-19).

16 Sep 2020

Candidate monoclonal antibody shows hope as COVID-19 treatment

Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) and its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

16 Sep 2020

Disease/Infection News

Seropositive partners increase risk of COVID-19 but not obstetric complications in pregnant women

Study shows why bacterial cells behave differently on different types of surfaces

Higher viral loads can increase mortality rate in patients hospitalized with COVID-19 and cancer

Blood viscometers could help guide the treatment of Covid-19 patients

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Data scientists use Zhores supercomputer to identify the severity of COVID-19

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

Changes in risk perception and protective behavior during coronavirus pandemic

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Pandemic spread could make more people susceptible to xenophobia, racism

Conditions linked to obesity leave the lungs of obese patients more susceptible to COVID-19

New York City’s initial lockdown reduced coronavirus spread by 70 percent, study says

CDC reports low mortality among children from COVID-19, but minorities are at risk

SARS-CoV-2 with D614G mutation is prevalent in central India

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

Low birth weight appears to increase risk of severe COVID-19 in adults

Candidate monoclonal antibody shows hope as COVID-19 treatment

Tough to tell COVID from smoke inhalation symptoms — and flu season’s coming

Lack of antigen test reporting leaves country ‘blind to the pandemic’

COVID vaccine trials move at warp speed, but recruiting Black volunteers takes time

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News